L35,36,37 CKD Pharmacology, Therapeutics, Labs

Description

PHCY310 Quiz on L35,36,37 CKD Pharmacology, Therapeutics, Labs, created by Mer Scott on 16/04/2019.
Mer Scott
Quiz by Mer Scott, updated more than 1 year ago
Mer Scott
Created by Mer Scott over 5 years ago
8
0

Resource summary

Question 1

Question
Three determinants of renin release: 1. Decreased [blank_start]Na+ concentration[blank_end] sensed by kidney 2. Decreased BP or renal [blank_start]blood flow[blank_end] 3. [blank_start]Beta 2[blank_end] receptor activation
Answer
  • Na+ concentration
  • blood flow
  • Beta 2

Question 2

Question
Angiotensin causes profound vasoconstriction and aldosterone release.
Answer
  • True
  • False

Question 3

Question
Both ACEIs and ARBS will decrease systemic vascular resistance and increase renal perfusion.
Answer
  • True
  • False

Question 4

Question
Diuretics for CKD: 1. Loop diuretics inhibit the activity of the Na-K-2Cl symporter in the [blank_start]thick ascending loop of Henle[blank_end]. Therefore maximum effect is ~[blank_start]20-25[blank_end]%. 2. Thiazide diuretics inhibit the activity of the Na-Cl symporter in the [blank_start]distal tubule[blank_end]. Maximum effect is ~[blank_start]5[blank_end]%. 3. K-sparing diuretics inhibit the activity of epithelial Na+ channels in the [blank_start]late distal tubule and collecting duct[blank_end]. Maximum effect is ~[blank_start]2[blank_end]%. 4. Aldosterone antagonists competitively inhibit the binding of [blank_start]aldosterone[blank_end] to the mineralocorticoid receptor. The only class of diuretics that do not enter the tubule cell from the apical ([blank_start]tubular[blank_end]) side, and instead from the basolateral ([blank_start]blood[blank_end]) side.
Answer
  • thick ascending loop of Henle
  • 20-25
  • distal tubule
  • 5
  • late distal tubule and collecting duct
  • 2
  • aldosterone
  • blood
  • tubular

Question 5

Question
Classification of CKD: • Normal/ CKD 1: GFR >90 mL/min • Mild/ CKD 2: GFR [blank_start]60-90[blank_end] mL/min • Moderate/ CKD 3: GFR [blank_start]30-60[blank_end] mL/min • Severe/ CKD 4: GFR [blank_start]15-30[blank_end] mL/min • End-stage/ CKD 5: GFR <15 mL/min
Answer
  • 60-90
  • 30-60
  • 15-30

Question 6

Question
Non-pharmacological treatment of CKD entails dietary sodium restriction, and protein restriction if GFR < 30mL/min.
Answer
  • True
  • False

Question 7

Question
When using ACEIs and ARBs in CKD the target is a reduction in urine [blank_start]albumin[blank_end] of 30-50%. Starting can [blank_start]reduce[blank_end] GFR; start at a [blank_start]low[blank_end] dose and titrate the dose slowly to effect. Other Important side effects to consider: • [blank_start]Hyper[blank_end]kalaemia • [blank_start]Acute[blank_end] renal impairment • Dry cough (fairly [blank_start]common[blank_end]) • Angioedema ([blank_start]rare[blank_end], but serious)
Answer
  • albumin
  • reduce
  • low
  • Hyper
  • Acute
  • common
  • rare

Question 8

Question
Methods of estimating renal function: 1. Creatinine-based methods (CLcr, eGFR) • Collection of 24 hour urine samples ([blank_start]creatinine[blank_end] clearance) • Cockcroft-Gault [blank_start]Equatoin[blank_end] (an estimate of creatinine clearance) • MDRD • CKD-EPI All these are reported by the lab as “[blank_start]eGFR[blank_end]”. 2. Cystatin C clearance 3. Clearance of a [blank_start]xenobiotic[blank_end]: Inulin (NOT insulin), 51Cr EDTA (radioisotope)
Answer
  • creatinine
  • Equation
  • eGFR
  • xenobiotic

Question 9

Question
Creatinine is freely filtered by the glomerulus and so its clearance lets us estimate GFR.
Answer
  • True
  • False

Question 10

Question
Cockcroft & Gault equation: CLcr = ( (140 - [blank_start]Age[blank_end]) x [blank_start]ideal body weight[blank_end] x K* ) / [blank_start]serum creatinine[blank_end] * K = 1.23 for males, 1.04 for females
Answer
  • age
  • ideal body weight
  • serum creatinine

Question 11

Question
All creatinine-based methods; • Are poor predictors of GFR if malnourished or low [blank_start]muscle[blank_end] mass • Over-estimate GFR in the elderly, [blank_start]obese[blank_end] (using total body weight), severe or end-stage renal disease • Not for <[blank_start]18[blank_end] years old • Unreliable when renal function [blank_start]changing[blank_end] rapidly (acute renal failure) • Drugs [blank_start]inhibiting[blank_end] tubular secretion can raise creatinine conc (e.g. probenecid, trimethoprim, spironolactone)
Answer
  • muscle
  • 18
  • changing
  • obese
  • inhibiting

Question 12

Question
In CKD, K+ secretion is [blank_start]reduced[blank_end] resulting in accumulation. Concentrations above [blank_start]5.5-6[blank_end]mmol/L become symptomatic. Hyperkalaemia is more likely to be observed in CKD 4 or 5, and is exacerbated by [blank_start]ACE-I, ARBs[blank_end] and K-sparing diuretics.
Answer
  • reduced
  • 5.5-6
  • ACE-I, ARBs

Question 13

Question
Match the ranges. - Creatinine (plasma): Adult male: 50-[blank_start]110[blank_end] µmol/L, Adult female: 45-[blank_start]90[blank_end] µmol/L - Urea (plasma): Adults: [blank_start]3.2-7.7[blank_end] mmol/L - Sodium (plasma) [blank_start]135-145[blank_end] mmol/L - Osmolality (plasma) 280-[blank_start]300[blank_end] mmol/kg - Osmolality (urine) 300-[blank_start]1200[blank_end] mmol/kg
Answer
  • 110
  • 90
  • 3.2-7.7
  • 135-145
  • 300
  • 1200
Show full summary Hide full summary

Similar

Physics equations
helensellers75
situation ethics
96arthur.g
Plate tectonics, earthquakes and volcanoes
Fleur Marie
Essay Outline
Kai Ladd
Biology (level 0)
jmlari12
Touloper
field.sophie
Resumo global da matéria de Biologia e Geologia (10.º e 11.º anos)_2
Bruna Simaens
Mrs Lyons - Blood Brothers
Harvey Symons
Test Primer Parcial - Tecnologías de la Información I
Ing. José Luis A. Hernández Jiménez
Music Therapy Practice Exam (with explanations)
Hannah Rebecca
AAHI_Card set 3 (Vital sign parameters - Adult)
Tafe Teachers SB